EMULATE - Certigroup Advisors

New York +1 347 696-1077
Hongkong +852 8191 -5145
Tokyo +81-3-3666-0141 ext. 115
UK +44-20-8123-5587
Go to content

Main menu:

IPO LISTINGS





EMULATE









Founded: 2013
 
Notable Investors: Glass Wall Syndicate
 
Headquarters: Boston MA, US
 
Total Funding: $202M

Current Valuation: $600M


 
About EMULATE


 
Emulate develops Organs-on-Chips technologies through an automated human bioemulation platform that aims to mimic true human physiology so that responses to medicines, chemicals, and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate aims to advance product innovation, design, and safety across a range of applications in drug development, personalized medicine, agriculture, and chemical-based consumer products.
 
 Emulate was founded in 2013 and is based in Bostom, MA. Notable investors in Emulate include Founders Fund, Glass Wall Syndicate, and Starlight Ventures.


Investors

 
ALS Finding a Cure
 
Emulate
 
 

ALS Investment Fund
 
Emulate, Verge Genomics
 
 

Alumni Ventures Group
 
Lacework, Getaround, GrubMarket, Better.com, Groq, Divergent 3D, SonderMind, Plastiq, Accolade, Madison Reed
 
 

ATEL Ventures
 
Emulate
 
 

Blue Ivy Ventures
 
Wheels Up, Divergent 3D, Plastiq, Upstart, Emulate, Shift, OpenGov, Tamr, Freshly, Humatics
 
 

Cedars Sinai Medical Center
 
Emulate
 
 

Founders Fund
 
Lyft, SpaceX, Spotify, Airbnb, Stripe, Anduril Industries, Flexport, Palantir Technologies, Wish, Compass
 
 

Glass Wall Syndicate
 
Emulate
 
 

LabCorp
 
Emulate
 
 

NanoDimension
 
View, Inscripta, Emulate, SQZ Biotech
 
 

National Institutes of Health
 
Emulate, Owlet Baby Care
 
 

Northpond Ventures
 
Emulate
 
 

OS Fund
 
Pivot Bio, Emulate, Tempo Automation, Human Longevity, Verge Genomics, Elysium Health, uBiome, 3T Biosciences
 
 

Perceptive Advisors
 
Zymergen, Freenome, Omada Health, Crossover Health, Twin Health, Emulate, PROCEPT BioRobotics, AEGEA Medical, Saama
 
 

SciFi VC
 
Zymergen, PsiQuantum, Anchorage Digital, Synthego, Virta Health, Emulate
 
 

Starlight Ventures
 
Emulate, Commonwealth Fusion, Carbon Engineering
 
 

Techammer
 Cityblock Health, EverlyWell, Imperfect Foods, Emulate, Pymetrics



Funding History
July 2014 $12.0M
March 2016 $45.0M
June 2018
$36.0M
August 2019
$28.2M
August 2020$20.7M
August 2021$60.4M


Management

 
Chief Executive Officer
Jim Corbett

Chief Financial Officer
Scott Kantor



Contact us for information or any queries related to financial investments
OUR СОRЕ PHILOSOPHY
________________________
_______________
SITEMAP
Certigroup Advisors rеvоlvеѕ аrоund twо key аѕресtѕ:
fіrѕt, we believe іn lоng-tеrm value investing, whеrе wе look
at an investment hоrіzоn of at lеаѕt 2-3 years. Sесоndlу, we
focus оn bоttоm-uр ѕtосk рісkіng using fundаmеntаl rеѕеаrсh.
© Certigroup Advisors 2023
All Rights Reserved.
_____________________
_____________________
_____________________
_____________________
US TRADING OFFICE
55 Wall Street,
8th Floor,
New York, NY 10005
Tel : +1 347 696-1077
trade@certigroupadvisors.com
Back to content | Back to main menu